Peak Bio, Inc.
SEC CIK 1834645 · PKBO · last insider filing 2024-12-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Ikbc-SBI BIO Fund 1 | Director | filed 2023 - 2024 |
| SBI Cross-Border Advantage Fund | Director | filed 2023 - 2024 |
| SBI Healthcare Fund I | Director | filed 2023 - 2024 |
| SBI Investment Korea CO., LTD. | Director | filed 2023 - 2024 |
| Huh Hoyoung | Director | filed 2022 - 2024 |
| Neal James R | Director | filed 2022 - 2024 |
| Patel Sandip I | Director | filed 2024 - 2024 |
| Lamond Stephen J | Director · See Remarks | filed 2022 - 2023 |
| Friedman Michael R. | Director | filed 2023 - 2023 |
| Elam Nevan C | Director | filed 2022 - 2022 |
| Rosenberg David I. | Director · Co-Chief Executive Officer | filed 2021 - 2022 |
| Strupp David J. | Director · Co-Chief Executive Officer | filed 2021 - 2021 |
| Kaplan Steven Neil | Director · Chief Financial Officer | filed 2021 - 2021 |
| Rosenstock Richard J | Director | filed 2021 - 2021 |
| Cohen Cheryl | Director | filed 2021 - 2021 |
| Wilson Charles | Director | filed 2021 - 2021 |
| Boockvar John Andrew | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mccabe Peter David | General Counsel | filed 2023 - 2023 |
| Cunningham Timothy M. | Acting Chief Financial Officer | filed 2022 - 2022 |
| Mitra Satyajit Kumar | See Remarks | filed 2022 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.